Feasibility of Passive Data Collection in Dementia Subjects With Agitation

Sponsor
HealthMode Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT04413851
Collaborator
(none)
1
2
18.2
0.5
0

Study Details

Study Description

Brief Summary

This is a multi-center, observational, feasibility study, to evaluate long term passive data collection, data quality, and user experience of HealthMode Agitation (Apps) to collect motion, location, physiological, and audio data; and eCOA and EMA responses with mobile devices (iPhone, Apple Watch).

The purpose of this study is to evaluate and improve HealthMode Apps data collection and usability in subjects experiencing agitation in the context of dementia.

Study Design

Study Type:
Observational
Actual Enrollment :
1 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Feasibility Study to Evaluate Passive Collection of Activity Data in Subjects With Agitation in the Context of Dementia
Actual Study Start Date :
Jun 1, 2020
Actual Primary Completion Date :
Dec 6, 2021
Actual Study Completion Date :
Dec 6, 2021

Arms and Interventions

Arm Intervention/Treatment
Dementia

Subjects with a diagnosis of dementia who are experiencing agitation severe enough that it interferes with activities of daily living or social interaction.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of passive and continuous data collection [28 days]

    Total time and percentage of continuous data collection for each stream of data aiming for >50% coverage.

Secondary Outcome Measures

  1. Tolerability of carrying a smartphone and wearing a data collection sensor on the wrist and/or hand in a population of subjects who may have frequent episodes of agitation or impulsive behavior. [28 days]

    Caregiver and Staff engagement with the eCOA and EMA (threshold 80% completion) and responses to usability questionnaires at week 1 and 4 to provide feedback on comfort, usability and engagement. The score ranges from 10 to 50, higher score indicating a better usability.

Other Outcome Measures

  1. Suitability of individual data streams and their combinations for purposes of identification of agitation episodes in passively collected data. [28 days]

    Comparison of data collected from the smartphone and wearable device to episodes identified by subject or caregiver assessment: Cleaned single channel data compared to assessments Cleaned multichannel data compared to assessments Analyzed multichannel data compared to assessments Subject/Caregiver assessment data compared to agitation scale ratings Agitation scale ratings compared to cleaned single and multichannel data and analyzed multichannel data. Merged subject/caregiver assessment and multichannel data compared to agitation scale ratings

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male and female subjects 18 years and older.

  • Subjects who have met DSM-5 criteria for Dementia (all cause)

  • Subjects with a recent history of agitation in the past 6 months to a point that impairs social activities, requires staffing or medical intervention (kick, bite, flailing, etc.), impairs ability for functional activities of daily living, as disclosed by a caregiver or documented in the medical record.

  • Subjects resident in a group home, nursing home, or assisted living are eligible to participate.

  • Subjects who can read, understand and provide written informed consent or who have a Legally Acceptable Representative (LAR)

  • Subjects who are willing and able to carry a smartphone and wear an activity tracker on their wrist or hand, alone or with the help of a caregiver.

  • Subjects who, either alone or with a caregiver, are able to operate a smartphone and wrist or hand-worn activity tracker, alone or with the help of a caregiver.

  • Subjects who are in good general health prior to study participation as determined by a detailed medical history, and in the opinion of the Principal Investigator.

  • Subjects, who are able to ambulate without an assistive device, or with a single point cane.

Exclusion Criteria:
  • Subjects who are unwilling or unable to carry a smartphone and wear an activity tracker on their wrist or hand.

  • Subjects with serious or unstable medical illnesses. These include current hepatic (moderate-severe hepatic impairment), renal, gastroenterological, respiratory, cardiovascular (including ischemic heart disease, congestive heart failure), endocrinologic, neurologic or hematologic disease.

  • Subjects who are considered by the investigator, for any reason, to be an unsuitable candidate.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tucson Neuroscience Research, LLC Tucson Arizona United States 85710
2 Virtual Research Site New York New York United States 10001

Sponsors and Collaborators

  • HealthMode Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
HealthMode Inc.
ClinicalTrials.gov Identifier:
NCT04413851
Other Study ID Numbers:
  • HM060401
First Posted:
Jun 4, 2020
Last Update Posted:
Dec 17, 2021
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 17, 2021